prostap unknown
clear pharma limited - leuprorelin acetate - unknown - gonadotropin releasing hormone analogues
depo-eligard 22.5 mg inj. sol. (pwdr. + solv.) s.c. pre-filled syr.
recordati industria chimica e farmaceutica s.p.a. - leuprorelin acetate 22,5 mg - eq. leuprorelin 20,87 mg - powder and solvent for solution for injection - 22,5 mg - leuprorelin acetate 22.5 mg - leuprorelin
depo-eligard 7.5 mg inj. sol. (pwdr. + solv.) s.c. pre-filled syr.
recordati industria chimica e farmaceutica s.p.a. - leuprorelin acetate 7,5 mg - eq. leuprorelin 6,96 mg - powder and solvent for solution for injection - 7,5 mg - leuprorelin acetate 7.5 mg - leuprorelin
leuprolide hexal 5 implant
sandoz sa (pty) ltd - leuprorelin acetate - implant - each implant contains leuproreline acetate equivalent to leuproreline 5,0 mg
leuprolide hexal 3 implant
sandoz sa (pty) ltd - leuprorelin acetate - implant - each implant contains leuproreline acetate equivalent to leuproreline 3,6 mg
lucrin pds depot 11.25 mg
abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - powder and solvent for suspension for injection - leuprorelin acetate 11.25 mg - leuprorelin - endometriosis, prostatic cancer, treatment of uterine fibroids for a period of up to six months. treatment of breast cancer in pre- and peri - menopausal women in whom hormone therapy is specified.
lucrin pds depot 11.25 mg
abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - powder and solvent for suspension for injection - leuprorelin acetate 11.25 mg - leuprorelin - endometriosis, prostatic cancer, treatment of uterine fibroids for a period of up to six months. treatment of breast cancer in pre- and peri - menopausal women in whom hormone therapy is specified.
lucrin pds depot 3.75 mg
abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - powder and solvent for suspension for injection - leuprorelin acetate 3.75 mg - leuprorelin - endometriosis prostatic cancer treatment of uterine fibroids for a period of up to six months. treatment of breast cancer in pre- and peri - menopausal women in whom hormone therapy is specified.
lucrin pds depot 3.75 mg
abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - powder and solvent for suspension for injection - leuprorelin acetate 3.75 mg - leuprorelin - endometriosis prostatic cancer treatment of uterine fibroids for a period of up to six months. treatment of breast cancer in pre- and peri - menopausal women in whom hormone therapy is specified.
lucrin injection 5 mgml
abbvie pte. ltd. - leuprorelin acetate - injection - 5 mg/ml - leuprorelin acetate 5 mg/ml